December 1, 2025 · Form 4 insider transaction
Guyer William bought 224 shares of Corcept Therapeutics Incorporated at $79.78 per share, a transaction worth $17.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 1, 2025.; In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.